It’s possible. According to the FDA, the anti-diabetic drug Byetta can cause an increased risk of acute pancreatitis and altered kidney function. Shortly after the drug was released in 2005, several cases of pancreatitis were reported—including hemorrhagic and necrotizing pancreatitis—prompting the FDA to release a Risk Evaluation and Mitigation Strategy in 2009 that warned against the dangers of these serious side effects. However, the drug remained on the market, and over 7 million prescriptions for Byetta have been filled to date.
As part of its efforts to minimize risk, the FDA has urged doctors to educate their patients about the risks and early symptoms of pancreatitis to avoid the development of pancreatic cancer cells. Doctors must be vigilant about testing patients who are taking Byetta to detect the signs of pancreatic cancer as early as possible. If the diagnosis is made after the cancer has been allowed to spread, it is far less likely that any treatment will be effective against the disease.
Here are a few diagnostic tests that can help doctors detect the symptoms of Byetta pancreatic cancer:
- CT scan of the chest, back, and abdomen
- ERCP (endoscopic retrograde cholangiopancreatography)
- Endoscopic ultrasound
- Abdominal MRI
- Biopsy of the pancreas
If someone in your family has developed cancer from taking Byetta in KY, our Louisville diabetes drug attorneys can help you seek justice. Call Gray and White today at 888.450.4456 or fill out the contact form on the top of this page to get started on your FREE, one-on-one consultation. The call is free, and you owe is nothing unless we win your case.